Biotech Consulting & Company Creation
Life Science Strategy
Seed to Series A
Investor Engagements
Biotech Consulting & Company Creation
Life Science Strategy
Seed to Series A
Investor Engagements
Life science partner for early-stage biotech entrepreneurs
COMPANY CREATION
COMPANY CREATION
COMPANY CREATION
- Biotech consulting, advisor & mentor
- Interim CEO, CSO, VP
- Founding, seed & series A
- Team recruitment
- Intellectual property & partnering
SCIENCE STRATEGY
COMPANY CREATION
COMPANY CREATION
- Therapeutic product profiles
- Manufacturing & development plans
- Resourcing, budgets & timelines
- Competitive due diligence
- Science, KOL & CRO management
FUND RAISING
COMPANY CREATION
DRUG MODALITIES
- Seed & series A funding strategy
- Compelling pitch decks
- Introductions to venture capital
- Roadshow participation
- Impactful first meetings
DRUG MODALITIES
DISEASE EXPERTISE
DRUG MODALITIES
- Recombinant proteins
- Antibody fusions & conjugates
- Viral & non-viral gene therapies
- Antisense oligonucleotides
- Small molecules
- Dermal aesthetics
DISEASE EXPERTISE
DISEASE EXPERTISE
DISEASE EXPERTISE
- Muscular dystrophy & neuromuscular disease
- Brain & peripheral nervous system disease
- Metabolic disease of liver, heart & kidney
- Skin & connective tissue disorders
About
Dr. Hodges enjoys helping fellow entrepreneurs develop great technology and raise money. His unique perspective guides all levels of company creation, from founding idea to series A road show.
Please email bradhodges@maytrex.com to schedule an introductory call.
Experienced biotech founder and executive scientist with track record of $200M+ grant, seed, partnering & series A funding. Story creation, plans, budgets, pitch decks, partnering, introductions to venture capital, roadshow participation & impactful first meetings. Pitched to hundreds of companies and VCs. 200+ program reviews – from discovery to commercial.
25 years of experience across 40+ early-stage programs; complex biologics, antibody fusions & conjugates, viral & non-viral gene therapies, antisense oligonucleotides, small molecules, and injectable aesthetics. Therapeutic product profiles, analytical methods, manufacturing, preclinical & clinical development plans, team recruitment, budgets & timelines. KOL & CRO management, competitive due diligence, intellectual property, regulatory filings & 30+ publications.
Deep expertise and champion for those affected by rare diseases, including muscular dystrophy and other neuromuscular disorders (DMD/LAMA2/Col6/FSHD/DM1/MTM/Pompe), metabolic disorders (MPS/Canavan/Batten/Lafora/CblC), liver diseases (GSD/LSD), skin and connective tissue disorders (Col7/LAM-332/EDS4) & kidney disease (Fabry/FSGS/Alport/Pierson)